| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5536319 | Vaccine | 2017 | 6 Pages |
Abstract
In conclusion this study showed that it is feasible to develop a polyvalent AHSV vaccination regime based on the use of combinations of MVA-VP2 viruses.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Nicola Mary Manning, Katarzyna Bachanek-Bankowska, Peter Paul Clement Mertens, Javier Castillo-Olivares,